Contact Professor Goran Roos
Background
Göran is a Visiting Professor at Cranfield's Centre for Business Performance. He holds an Advanced Postgraduate Diploma in Management Consultancy from Henley Management College, Henley-on-Thames, England, an MBA in Strategy from INSEAD, Fontainebleau, France and a MSc in Engineering Physics, Chalmers University of Technology, Göteborg, Sweden. He has held management positions in both American and European firms and have lived in Sweden, Norway, Japan, France and US before moving to England.
Göran has founded or co-founded, managed and in some cases successfully divested 15 companies during 20 years. The companies have all been knowledge based and have had or have domicile in UK, Norway, Sweden, Finland, Australia and the US. He is one of the founders of the modern field of intellectual capital and have published books, articles and case studies on the subject as well as on the wider subject of strategy. Göran's consulting experience in this field ranges across both public and private sectors in over 40 countries.
Göran holds academic positions at Helsinki School of Economics' Centre for Executive Education in Finland and Mt. Eliza Business School in Australia. Göran has previously held positions at the Norwegian School of Management, Kaunas University of Technology in Lithuania and the Institute for Policy Science in Japan.
Göran's principal interests lie in helping clients extracting more value from their intangible assets.
Publications
Articles In Journals
- Roos G. (2021). Preface. E3S Web of Conferences, 291
- Roos G, Drok TE, Novikova A & Farafonova Y. (2021). Subnational economic complexity analysis: case-study of the Kaliningrad region. E3S Web of Conferences, 291
- Roos G, Kubina NY & Farafonova YY. (2021). Opportunities for sustainable economic development in coastal territories of the Baltic Sea Region in the context of digital transformation. Baltic Region, 13(2)
- Tumkur Sitaram R, Landström M, Roos G & Ljungberg B. (2021). Significance of PI3K signalling pathway in clear cell renal cell carcinoma in relation to VHL and HIF status. Journal of Clinical Pathology, 74(4)
- Roos G, Voloshenko KY, Drok TE & Zverev YM. (2020). European countries’ typology by the intensity of transboundary cooperation and its impact on the economic complexity level. GEOGRAPHY, ENVIRONMENT, SUSTAINABILITY, 13(1)
- Roos G, Voloshenko KY, Drok TE & Farafonova YY. (2020). AN ECONOMIC COMPLEXITY ANALYSIS OF THE KALININGRAD REGION: IDENTIFYING SECTORAL PRIORITIES IN THE EMERGING VALUE CREATION PARADIGM. BALTIC REGION, 12(1)
- Roos G. (2018). Resource deployment system implications of migrating the firm into a digital value creation paradigm. Knowledge Management Research & Practice, 16(3)
- Reynolds C, Agrawal M, Lee I, Zhan C, Li J, .... (2018). A sub-national economic complexity analysis of Australia’s states and territories. Regional Studies, 52(5)
- Roos G & Shroff Z. (2017). What will happen to the jobs? Technology-enabled productivity improvement – good for some, bad for others. Labour & Industry: a journal of the social and economic relations of work, 27(3)
- Saarela M & Roos G. (2017). Succeeding in the Asian luxury food market. Agro Food Industry Hi Tech, 28(4)
- Roos G. (2017). Knowledge management, intellectual capital, structural holes, economic complexity and national prosperity. Journal of Intellectual Capital, 18(4)
- Roos G. (2016). Design-Based Innovation for Manufacturing Firm Success in High-Cost Operating Environments. She Ji: The Journal of Design, Economics, and Innovation, 2(1)
- Svenson U, Öberg Å, Stenling R, Palmqvist R & Roos G. (2016). Telomere length in peripheral leukocytes is associated with immune cell tumor infiltration and prognosis in colorectal cancer patients. Tumor Biology, 37(8)
- O'Connor A, Du K & Roos G. (2015). The intellectual capital needs of a transitioning economy. Journal of Intellectual Capital, 16(3)
- Roos G & O'Connor A. (2015). Government policy implications of intellectual capital: an Australian manufacturing case study. Journal of Intellectual Capital, 16(2)
- Ahlqvist T, Kettle J, Roos G & Vanderhoek N. (2015). The South Australian Value Chain Study. APPITA, 68(1)
- Roos G. (2014). Business Model Innovation to Create and Capture Resource Value in Future Circular Material Chains. Resources, 3(1)
- Roos G & Kennedy N. (2014). Global perspectives on achieving success in high and low cost operating environments. Global Perspectives on Achieving Success in High and Low Cost Operating Environments
- Ueda Y, Calado RT, Norberg A, Kajigaya S, Roos G, .... (2014). A mutation in the H/ACA box of telomerase RNA component gene (TERC) in a young patient with myelodysplastic syndrome. BMC Medical Genetics, 15(1)
- Burton K, O'Connor A & Roos G. (2013). An empirical analysis of the IC Navigator approach in practice – a case study of five manufacturing firms. Knowledge Management Research & Practice, 11(2)
- Roos G, Kettle J & Vanderhoek N. (2013). Realisation of the potential in the forest industry sector through innovation, technology and commercialisation. Appita Journal, 66(2)
- Kettle J, Roos G, Vanderhoek N, Harlin A & Allender B. (2012). Is the Australian pulp and paper Industry still at the crossroads?. Appita Journal, 65(3)
- Peng TA, Pike S, Yang JC & Roos G. (2012). Is Cooperation with Competitors a Good Idea? An Example in Practice. British Journal of Management, 23(4)
- Melin BS, Nordfjäll K, Andersson U & Roos G. (2012). h
TERT Cancer Risk Genotypes Are Associated With Telomere Length. Genetic Epidemiology, 36(4) - Peng TJA, Yang JCH, Pike S & Roos G. (2011). Intellectual capitals, business models and performance measurements in forming strategic network. International Journal of Learning and Intellectual Capital, 8(3)
- Varadi V, Brendle A, Brandt A, Johansson R, Enquist K, .... (2009). Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis. European Journal of Cancer, 45(17)
- Thunberg U, Amini R, Linderoth J, Roos G, Enblad G, .... (2009). BCL2 expression in de novo Diffuse Large B‐cell Lymphoma partly reflects normal differences in age distribution. British Journal of Haematology, 146(6)
- Berglund M, Roos G & Thunberg U. (2009). Thymidylate syntase polymorphism relevant for survival in patients with diffuse large B-cell lymphoma?. Leukemia & Lymphoma, 50(10)
- Hansson M, Zendehrokh N, Ohyashiki J, Ohyashiki K, Westman U-B, .... (2008). Telomerase Activity in Effusions: A Comparison Between Telomere Repeat Amplification Protocol In Situ and Conventional Telomere Repeat Amplification Protocol Assay. Archives of Pathology & Laboratory Medicine, 132(12)
- Nordfjäll K, Eliasson M, Stegmayr B, Lundin S, Roos G, .... (2008). Increased abdominal obesity, adverse psychosocial factors and shorter telomere length in subjects reporting early ageing; the MONICA Northern Sweden Study. Scandinavian Journal of Public Health, 36(7)
- Svenson U, Nordfjäll K, Stegmayr B, Manjer J, Nilsson P, .... (2008). Breast Cancer Survival Is Associated with Telomere Length in Peripheral Blood Cells. Cancer Research, 68(10)
- Linderoth J, Edén P, Ehinger M, Valcich J, Jerkeman M, .... (2008). Genes associated with the tumour microenvironment are differentially expressed in curedversusprimary chemotherapy‐refractory diffuse large B‐cell lymphoma. British Journal of Haematology, 141(4)
- Peng TA, Pike S & Roos G. (2007). Intellectual capital and performance indicators: Taiwanese healthcare sector. Journal of Intellectual Capital, 8(3)
- Ylä-Anttila P, Kulmala HI & Roos G. (2007). Innovation management - A success factor for competitiveness. VTT Symposium Valtion Teknillinen Tutkimuskeskus
- O'Connor A, Roos G & Vickers‐Willis T. (2007). Evaluating an Australian public policy organization's innovation capacity. European Journal of Innovation Management, 10(4)
- Burgman R & Roos G. (2007). The importance of intellectual capital reporting: evidence and implications. Journal of Intellectual Capital, 8(1)
- Burgman R, Roos G, Christmas LB & Pike S. (2007). Information needs of internal and external stakeholders and how to respond: reporting on operations and intellectual capital. International Journal of Accounting, Auditing and Performance Evaluation, 4(4/5)
- Linderoth J, Ehinger M, Jerkeman M, Bendahl P-O, Åkerman M, .... (2007). CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma. Leukemia & Lymphoma, 48(9)
- Pike S, Christmas LB & Roos G. (2006). Intellectual capital: origin and evolution. International Journal of Learning and Intellectual Capital, 3(3)
- Pike S, Roos G & Marr B. (2005). Strategic management of intangible assets and value drivers in R&D organizations. R and D Management, 35(2)
- Roos G. (2005). Intellectual capital and strategy: a primer for today’s manager. Handbook of Business Strategy, 6(1)
- Roos G, Pike S & Fernstrom L. (2005). Valuation and reporting of intangibles ? state of the art in 2004. International Journal of Learning and Intellectual Capital, 2(1)
- Pike S, Fernström L & Roos G. (2005). Intellectual capital. Journal of Intellectual Capital, 6(4)
- Burgman RJ, Roos G, Ballow JJ & Thomas RJ. (2005). No longer “out of sight, out of mind”. Journal of Intellectual Capital, 6(4)
- Nordfjäll K, Larefalk Å, Lindgren P, Holmberg D & Roos G. (2005). Telomere length and heredity: Indications of paternal inheritance. Proceedings of the National Academy of Sciences, 102(45)
- Norén-Nyström U, Roos G, Bergh A & Forestier E. (2005). Prognostic impact of vascular density and fibrosis in the bone marrow of children with high-risk acute lymphoblastic leukemia. Leukemia, 19(11)
- Burgman R & Roos G. (2004). Measuring, managing and delivering value performance in the public sector. International Journal of Learning and Intellectual Capital, 1(2)
- Fernstrom L, Pike S & Roos G. (2004). Understanding the truly value creating resources ? the case of a pharmaceutical company. International Journal of Learning and Intellectual Capital, 1(1)
- Gray D, Roos G & Rastas T. (2004). What intangible resources do companies value, measure, and report? A synthesis of UK and Finnish research. International Journal of Learning and Intellectual Capital, 1(3)
- Pike S & Roos G. (2004). Mathematics and modern business management. Journal of Intellectual Capital, 5(2)
- Roos G, Fernström L & Pike S. (2004). Human resource management and business performance measurement. Measuring Business Excellence, 8(1)
- Marr B, Gupta O, Pike S & Roos G. (2003). Intellectual capital and knowledge management effectiveness. Management Decision, 41(8)
- Fletcher A, Guthrie J, Steane P, Roos G & Pike S. (2003). Mapping stakeholder perceptions for a third sector organization. Journal of Intellectual Capital, 4(4)
- Norén-Nyström U, Eriksson M, Eriksson B, Roos G, Bergh A, .... (2003). Antitumor activity of the angiogenesis inhibitor TNP-470 on murine lymphoma/leukemia cells in vivo and in vitro. Experimental Hematology, 31(2)
- Roos G, Bainbridge A & Jacobsen K. (2002). Intellectual capital analysis as a strategic tool. IEEE Engineering Management Review, 30(3)
- Gupta O & Roos G. (2001). Mergers and acquisitions through an intellectual capital perspective. Journal of Intellectual Capital, 2(3)
- Roos G, Bainbridge A & Jacobsen K. (2001). Intellectual capital analysis as a strategic tool. Strategy & Leadership, 29(4)
- Rylander A, Jacobsen K & Roos G. (2000). Towards improved information disclosure on intellectual capital. International Journal of Technology Management, 20(5/6/7/8)
- Bontis N, Dragonetti NC, Jacobsen K & Roos G. (1999). The knowledge toolbox:. European Management Journal, 17(4)
- Eriksson B, Johansson A-S, Roos G, Levan G & Holmberg D. (1999). Establishment and characterization of a mouse strain (TLL) that spontaneously develops T-cell lymphomas/leukemia. Experimental Hematology, 27(4)
- Roos G, Nilsson P, Cajander S, Nielsen N-H, Arnerlöv C, .... (1998). Telomerase activity in relation to p53 status and clinico-pathological parameters in breast cancer. International Journal of Cancer, 79(4)
- Norrback KF, Enblad G, Erlanson M, Sundström C & Roos G. (1998). Telomerase activity in Hodgkin's disease. BLOOD, 92(2)
- Roos G & Roos J. (1997). Measuring your company's intellectual performance. Long Range Planning, 30(3)
- Roos G & Roos J. (1997). Measuring your company's intellectual performance. Long Range Planning, 30(3)
- Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, .... (1997). The Heidelberg classification of renal cell tumours. The Journal of Pathology, 183(2)
- Norrback K-F & Roos G. (1997). Telomeres and telomerase in normal and malignant haematopoietic cells. European Journal of Cancer, 33(5)
- Landberg G, Nielsen NH, Nilsson P, Emdin SO, Cajander J, .... (1997). Telomerase activity is associated with cell cycle deregulation in human breast cancer. CANCER RESEARCH, 57(3)
- Norrback KF, Dahlenborg K, Carlsson R & Roos G. (1996). Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood, 88(1)
- Lenner P, Roos G, Hedenus M & Lindh J. (1989). SIMULTANEOUS PRESENTATION OF RELAPSING NON‐HODGKIN'S LYMPHOMA AND HODGKIN'S DISEASE. European Journal of Haematology, 42(3)
- Marklund SL, Westman NG, Roos G, Carlsson J, Roos G, .... (1984). Radiation Resistance and the CuZn Superoxide Dismutase, Mn Superoxide Dismutase, Catalase, and Glutathione Peroxidase Activities of Seven Human Cell Lines. Radiation Research, 100(1)
- MARKLUND SL, WESTMAN NG, LUNDGREN E & ROOS G. (1982). COPPER-CONTAINING AND ZINC-CONTAINING SUPEROXIDE-DISMUTASE, MANGANESE-CONTAINING SUPEROXIDE-DISMUTASE, CATALASE, AND GLUTATHIONE-PEROXIDASE IN NORMAL AND NEOPLASTIC HUMAN CELL-LINES AND NORMAL HUMAN-TISSUES. CANCER RESEARCH, 42(5)
- Sinna GA, Beckman G, Lundgren E, Nordenson I & Roos G. (1979). Characterization of two new human ovarian carcinoma cell lines. Gynecologic Oncology, 7(3)
- Lundgren E, Damber MG, Roos G, von Schoultz B, Stigbrand T, .... (1979). Cell lines with spontaneous secretion of pregnancy‐associated α2‐globulin. International Journal of Cancer, 24(1)
- Björkstén B, Holmgren G, And GR & Stenling R. (1978). Congenital Dyserythropoietic Anaemia Type III: an Electron Microscopic Study. British Journal of Haematology, 38(1)
- LUNDGREN E & ROOS G. (1976). CELL-SURFACE CHANGES IN HELA-CELLS AS AN INDICATION OF CELL-CYCLE EVENTS. CANCER RESEARCH, 36(11)
Conference Papers
- Lee I, Xia F & Roos G. (2017). An Observation of Research Complexity in Top Universities Based on Research Publications
- Roos G. (2017). The IC-Navigator as a Solution to Part of the Critique Directed at the Resource Based View of the Firm
- Touloumenidou T, Ntoufa S, Mansouri L, Papakonstantinou N, Sutton LA, .... (2014). DIFFERENT CLL STEREOTYPED SUBSETS, VARYING TELOMERE LENGTHS: A MEASURE OF DISTINCT PROLIFERATIVE HISTORIES LINKED WITH UNIQUE CLINICOBIOLOGICAL FEATURES
- Roos G. (2011). Telomeres and human disease
- Svenson U & Roos G. (2009). Telomere length as a biological marker in malignancy
- Pike S & Roos G. (2007). Recent advances in the measurement of intellectual capital: A critical survey
- Linderoth J, Edén P, Ehinger M, Valcich J, Jerkeman M, .... (2007). Genes and Proteins Associated with the Tumor Microenvironment Are Differentially Expressed in Cured Versus Primary Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma.
- Li A, Westman U-B, Golovleva I, Kutok JL, Silverman LB, .... (2007). Wilms Tumor 1 Gene (WT1) Isoforms in Leukemia and Lymphoma.
- Norén-Nyström U, Roos G, Bergh A, Thörn I, Lonnerholm G, .... (2006). Bone Marrow Fibrosis Evaluation in Childhood Acute Lymphoblastic Leukaemia: Correlation to Biological Factors and Treatment Response.
- Buijs J, van Pul C, Roos G, Janssen M & Wijn P. (2004). Diffusion tensor MRI in neonatal ischernic brain damage: Changes of apparent diffusion coefficient and fractional anisotropy
- Buijs J, van Pul C, Roos G, Janssen M & Wijn P. (2004). Diffusion tensor MRI of the neonatal brain: Which anisotropy index should be used
- Rosenquist R, Holmberg D, Lindstrom A, Roos G & Lindh J. (1995). Clonal evolution in progressive lymphomas
- Ljungberg B, Mehle C & Roos G. (1995). Heterogeneity in renal cell carcinoma, prognostic significance
- Lundgren E, Hedman H, Landberg G, Chiang F, Roos G, .... (1991). Molecular events in B-cell activation and growth: Sensitivity to alpha interferon
- ROOS G & BERDEL WE. (1985). EFFECTS OF AN ALKYL-LYSOPHOSPHOLIPID DERIVATIVE ON HUMAN HEMATOPOIETIC-CELL LINES
Books
- Roos G. (2025). Managing Five-Generational Workforces Amid Labour Shortages and Technological Change In Advanced Labor Studies Research and Modern Practice. IGI Global.
- Matos F & Roos G. (2025). Introduction In Contributions to Management Science (Part F546).
- Bliemel M, Wixted B & Roos G. (2021). Case study: GVC vulnerability to disruption In Routledge Companion to Global Value Chains Reinterpreting and Reimagining Megatrends in the World Economy.
- Bliemel M, Wixted B & Roos G. (2021). Linking the interconnectedness and innovativeness of global value chains In The Routledge Companion to Global Value Chains. Routledge.
- Roos G. (2021). Operationalising the resource-based view of the firm In Research Handbook on Intellectual Capital and Business. Edward Elgar Publishing.
- Roos G & Pike S. (2018). Intellectual Capital as a Management Tool
- Roos G. (2017). Key Contributions to the Intellectual Capital Field of Study In The Routledge Companion to Intellectual Capital. Routledge.
- Roos G. (2017). Technology-Driven Productivity Improvements and the Future of Work
- Roos G & Agarwal R. (2015). Services Innovation in a Circular Economy In The Handbook of Service Innovation. Springer London.
- Agarwal R, Selen W, Roos G & Green R. Agarwal R, Selen W, Roos G & Green R (eds). (2015). The Handbook of Service Innovation
- Roos G. (2015). Servitization as Innovation in Manufacturing—A Review of the Literature In The Handbook of Service Innovation. Springer London.
- Kraatz JA, Hampson KD, Parker RL & Roos G. (2014). R&D Investment and Impact in the Global Construction Industry In Hampson K, Kraatz JA & Sanchez AX (eds), R and D Investment and Impact in the Global Construction Industry. Routledge.
- Roos G & Kennedy N. (2014). Global Perspectives on Achieving Success in High and Low Cost Operating Environments In Roos G & Kennedy N (eds), Global Perspectives on Achieving Success in High and Low Cost Operating Environments. IGI Global.
- Roos G. (2014). Manufacturing in a High Cost Environment In Advances in Business Strategy and Competitive Advantage. IGI Global.
- Roos G. (2014). The Intellectual Capital Navigator as a Strategic Tool In Advances in Business Strategy and Competitive Advantage. IGI Global.
- Roos G. (2014). Manufacturing in a High Cost Environment In Advances in Business Strategy and Competitive Advantage. IGI Global.
- Roos G. (2013). The Role of Intellectual Capital in Business Model Innovation In Intellectual Capital Strategy Management for Knowledge-Based Organizations. IGI Global.
- Roos G. (2012). An epistemology perspective on intellectual capital In Perspectives on Intellectual Capital.
- Marr B. (2012). Perspectives on Intellectual Capital In Perspectives on Intellectual Capital. Routledge.
- Pike S & Roos G. (2010). Measuring and Valuing Knowledge-Based Intangible Assets In Identifying, Measuring, and Valuing Knowledge-Based Intangible Assets. IGI Global.
- Pike S & Roos G. (2009). References In Destructive Leaders and Dysfunctional Organizations. Cambridge University Press.
- Roos G & Pike S. (2008). An intellectual capital view of business model innovation In Organisational Capital Modelling Measuring and Contextualising.
- Roos G & Pike S. (2008). Organisational Capital In Bounfour A(ed.), Organisational Capital Modelling Measuring and Contextualising. Routledge.
- Roos G, Roos G, Pike S & Fernstrom L. (2007). Managing Intellectual Capital in Practice
- MARR B. (2005). A Strategy Perspective on Intellectual Capital In Perspectives on Intellectual Capital. Elsevier.
- ROOS G. (2005). An Episteology Perspective on Intellectual Capital In Perspectives on Intellectual Capital. Elsevier.
- Pike S, Rylander, A & Roos G. (2002). Intellectual Capital Management and Disclosure In The Strategic Management of Intellectual Capital and Organizational Knowledge. Oxford University PressNew York, NY.